# Abivax (ABVX) — Analyst Forecast

ABVX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/abvx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 16 | 2 | 0 | 18 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $118.00 | $143.00 | $155.00 | 4 |

Last price $92.38 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 22, 2026 | Barclays | Maintained | Overweight | $148.00 |
| Sep 22, 2026 | Wedbush | Maintained | Neutral | $118.00 |
| Sep 22, 2026 | Truist Securities | Maintained | Buy | $151.00 |
| Sep 10, 2026 | Goldman Sachs | Initiated Coverage | Buy | $155.00 |
| Jul 9, 2026 | Piper Sandler | Maintained | Overweight | $175.00 |
| Jul 2, 2026 | Truist Securities | Maintained | Buy | $155.00 |
| Jul 1, 2026 | Citizens | Maintained | Market Outperform | $187.00 |
| Jun 30, 2026 | BTIG | Maintained | Buy | $175.00 |
| Jun 30, 2026 | Wedbush | Maintained | Neutral | $110.00 |
| Jun 30, 2026 | Leerink Partners | Maintained | Outperform | $148.00 |
| Jun 30, 2026 | Jefferies | Upgraded | Hold → Buy | $158.00 |
| Jun 16, 2026 | BTIG | Maintained | Buy | $150.00 |
| Jun 2, 2026 | BTIG | Maintained | Buy | $150.00 |
| Jun 2, 2026 | Wedbush | Upgraded | Underperform → Neutral | $90.00 |
| Jun 2, 2026 | Morgan Stanley | Maintained | Overweight | $132.00 |
| Jun 2, 2026 | Jefferies | Downgraded | Buy → Hold | $90.00 |
| Jun 2, 2026 | Citizens | Maintained | Market Outperform | $187.00 |
| Jun 2, 2026 | Truist Securities | Maintained | Buy | $135.00 |
| May 26, 2026 | Citizens | Maintained | Market Outperform | $131.00 |
| Mar 24, 2026 | Barclays | Maintained | Overweight | $148.00 |

## Frequently Asked Questions

### What is the price target for ABVX stock?

The average 12-month analyst price target for Abivax (ABVX) is $143.00, with a high estimate of $155.00 and a low of $118.00, across 4 analysts.

### Is ABVX a buy, sell, or hold?

Analysts covering Abivax currently average a Buy rating: 16 buy, 2 hold and 0 sell, from 18 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ABVX?

The average price target of $143.00 implies 54.80% upside from the last price of $92.38.

### What is the latest analyst rating on ABVX?

On Sep 22, 2026, Barclays maintained Abivax at Overweight with a price target of $148.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).